Can Ozempic Cause Left Lower Quadrant Abdominal Pain?
Yes, Ozempic (semaglutide) can cause left lower quadrant abdominal pain, and this symptom warrants immediate clinical evaluation to rule out serious gastrointestinal complications.
Understanding the Mechanism and Risk
The FDA-approved drug label explicitly lists "stomach (abdominal) pain" among the most common side effects of Ozempic 1. While the label describes generalized abdominal pain, emerging evidence demonstrates that semaglutide can cause specific, localized gastrointestinal pathology that may present as left lower quadrant pain.
Serious Complications to Consider
When a patient on Ozempic presents with left lower quadrant pain, you must actively exclude:
Ischemic Colitis: A 2025 case report documented a 43-year-old woman without traditional risk factors who developed left lower quadrant pain and bloody diarrhea while taking semaglutide 2. Colonoscopy confirmed ischemic colitis, which resolved completely after discontinuing the medication. This represents a potentially serious complication that can occur even in patients lacking typical vascular risk factors.
Bowel Obstruction/Ileitis: Semaglutide has been associated with small bowel pseudo-obstruction and ileitis presenting with abdominal pain 3. While this typically causes more diffuse symptoms, it can manifest with localized pain patterns.
Pancreatitis: The FDA label specifically warns about pancreatitis, noting that patients should "stop using OZEMPIC and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting" 1. Though pancreatitis classically presents with epigastric or right upper quadrant pain radiating to the back, atypical presentations occur.
Appendicitis: A 2024 case report described appendicitis in a patient on semaglutide, theorizing that GLP-1 RA-induced gastrointestinal effects may increase risk of vermiform obstruction 4. This would present as right lower quadrant pain but highlights the spectrum of acute abdominal complications.
Clinical Approach to Left Lower Quadrant Pain on Ozempic
Immediate Red Flags Requiring Urgent Evaluation:
- Severe, persistent pain that doesn't resolve
- Bloody diarrhea or hematochezia
- Fever or signs of systemic illness
- Peritoneal signs on examination
- Leukocytosis
- Inability to tolerate oral intake
Diagnostic Workup:
- Detailed history: Duration of semaglutide use, dose escalation timeline, associated symptoms (nausea, vomiting, diarrhea, constipation, bloody stools)
- Physical examination: Focal tenderness, rebound, guarding, bowel sounds
- Laboratory studies: CBC with differential, metabolic panel, lipase, lactate
- Imaging: CT abdomen/pelvis with IV contrast to evaluate for colitis, bowel obstruction, appendicitis, or other acute pathology
- Consider colonoscopy if imaging suggests colitis or symptoms persist
Management Strategy
For mild, non-specific abdominal pain without red flags:
- Continue monitoring closely
- Ensure adequate hydration (critical given GLP-1 RA effects on gastric emptying) 1
- Consider dose reduction or temporary hold
- Counsel on eating smaller meals, avoiding high-fat/spicy foods 5
For moderate to severe pain or any red flag features:
- Discontinue semaglutide immediately
- Complete diagnostic workup as above
- Admit for observation if concerning features present
- Do not rechallenge if serious pathology confirmed
Important Clinical Caveats
Gastrointestinal side effects are extremely common with semaglutide, affecting up to 25% of patients (nausea) and 10% (vomiting/diarrhea) 5. However, the presence of common side effects should not lead to dismissal of potentially serious complications.
Delayed gastric emptying is a known pharmacologic effect of GLP-1 receptor agonists 6, which can predispose to various gastrointestinal complications beyond simple dyspepsia.
The case of ischemic colitis 2 is particularly concerning because it occurred in a patient without traditional cardiovascular risk factors, suggesting a direct drug effect rather than simply unmasking pre-existing disease.
Weight loss benefits do not justify ignoring persistent abdominal pain. While semaglutide demonstrates impressive efficacy for weight reduction (14.9% mean reduction in non-diabetic adults) 7, gastrointestinal adverse effects remain the primary reason for treatment discontinuation 5, 7.
Bottom Line for Clinical Practice
Left lower quadrant abdominal pain in a patient taking Ozempic should never be dismissed as a benign side effect without proper evaluation. The threshold for imaging and specialist consultation should be low, particularly if symptoms are severe, persistent, or accompanied by any red flag features. When serious pathology is identified, permanent discontinuation of semaglutide is warranted, and symptoms typically resolve after drug cessation 2, 3.